BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21464919)

  • 1. Increased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequences.
    Rolland M; Frahm N; Nickle DC; Jojic N; Deng W; Allen TM; Brander C; Heckerman DE; Mullins JI
    PLoS One; 2011 Mar; 6(3):e17969. PubMed ID: 21464919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher cross-subtype IFN-γ ELISpot responses to Gag and Nef peptides in Brazilian HIV-1 subtype B- and F1- than in C-infected subjects.
    Côrtes FH; Bello G; Vorsatz C; Pilotto JH; Guimarães ML; Grinsztejn B; Veloso VG; Pinto AR; Morgado MG
    Vaccine; 2013 Feb; 31(7):1106-12. PubMed ID: 23261042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
    Karlsson AC; Iversen AK; Chapman JM; de Oliviera T; Spotts G; McMichael AJ; Davenport MP; Hecht FM; Nixon DF
    PLoS One; 2007 Feb; 2(2):e225. PubMed ID: 17311088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiviral efficacy of HIV-specific CD8⁺ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate.
    Ranasinghe SR; Kramer HB; Wright C; Kessler BM; di Gleria K; Zhang Y; Gillespie GM; Blais ME; Culshaw A; Pichulik T; Simmons A; Rowland-Jones SL; McMichael AJ; Dong T
    PLoS Pathog; 2011 May; 7(5):e1001341. PubMed ID: 21589893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching and emergence of CTL epitopes in HIV-1 infection.
    Han C; Kawana-Tachikawa A; Shimizu A; Zhu D; Nakamura H; Adachi E; Kikuchi T; Koga M; Koibuchi T; Gao GF; Sato Y; Yamagata A; Martin E; Fukai S; Brumme ZL; Iwamoto A
    Retrovirology; 2014 May; 11():38. PubMed ID: 24886641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of HLA-B*5401-restricted HIV-1-Nef and Pol-specific CTL epitopes.
    Kitano M; Kobayashi N; Kawashima Y; Akahoshi T; Nokihara K; Oka S; Takighuchi M
    Microbes Infect; 2008 Jun; 10(7):764-72. PubMed ID: 18538615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specific immune responses to human immunodeficiency virus type 1 Gag, Tat, Rev and Nef proteins].
    Zhai S; Kang WZ; Yu X; Wang SY; Walker BD; Altfeld M; Sun YT
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):175-9. PubMed ID: 15766402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cytotoxic T-lymphocyte-mediated immune selection in a dominant human leukocyte antigen-B8-restricted cytotoxic T-lymphocyte epitope in Nef.
    Maurer K; Harrer EG; Goldwich A; Eismann K; Bergmann S; Schmitt-Haendle M; Spriewald B; Mueller SM; Harrer T;
    J Acquir Immune Defic Syndr; 2008 Jun; 48(2):133-41. PubMed ID: 18391752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides.
    Almeida RR; Rosa DS; Ribeiro SP; Santana VC; Kallás EG; Sidney J; Sette A; Kalil J; Cunha-Neto E
    PLoS One; 2012; 7(9):e45267. PubMed ID: 23028895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.
    Draenert R; Altfeld M; Brander C; Basgoz N; Corcoran C; Wurcel AG; Stone DR; Kalams SA; Trocha A; Addo MM; Goulder PJ; Walker BD
    J Immunol Methods; 2003 Apr; 275(1-2):19-29. PubMed ID: 12667667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Kim J; De La Cruz J; Lam K; Ng H; Daar ES; Balamurugan A; Yang OO
    Viral Immunol; 2018 Sep; 31(7):525-536. PubMed ID: 30059271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.
    Kaufmann DE; Bailey PM; Sidney J; Wagner B; Norris PJ; Johnston MN; Cosimi LA; Addo MM; Lichterfeld M; Altfeld M; Frahm N; Brander C; Sette A; Walker BD; Rosenberg ES
    J Virol; 2004 May; 78(9):4463-77. PubMed ID: 15078927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative dominance of Env-gp41-specific cytotoxic T lymphocytes responses in HIV-1 advanced infection.
    Zhuang Y; Sun Y; Zhai S; Huang D; Zhao S; Wang S; Kang W; Li X; Walker BD; Altfeld M; Yu XG
    Curr HIV Res; 2008 May; 6(3):239-45. PubMed ID: 18473787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of viral escape in HIV-1 Nef by STEP vaccination.
    Park SY; Mack WJ; Lee HY
    AIDS; 2016 Oct; 30(16):2449-2458. PubMed ID: 27427874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-layered Gag-specific immunodominant responses contribute to improved viral control in the CRF01_AE subtype of HIV-1-infected MSM subjects.
    Jiang F; Han X; Zhang H; Zhao B; An M; Xu J; Chu Z; Dong T; Shang H
    BMC Immunol; 2016 Aug; 17(1):28. PubMed ID: 27577610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trials.
    Zembe L; Burgers WA; Jaspan HB; Bekker LG; Bredell H; Stevens G; Gilmour J; Cox JH; Fast P; Hayes P; Vardas E; Williamson C; Gray CM
    PLoS One; 2011; 6(10):e26096. PubMed ID: 22022524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of T cell recognition of HIV type 1 consensus group M Gag and Nef peptides in a clade A1- and D-infected Ugandan population.
    Serwanga J; Mugaba S; Pimego E; Nanteza B; Lyagoba F; Nakubulwa S; Heath L; Nsubuga RN; Ndembi N; Gotch F; Kaleebu P
    AIDS Res Hum Retroviruses; 2012 Apr; 28(4):384-92. PubMed ID: 21867408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.